London, UK; Brentwood, TN, US: 24 June 2008 - Protherics PLC (“Protherics” or the “Company”), the international biopharmaceutical company focused on critical care and cancer, announces that the Company’s Annual Report and Financial Statements for the year ended 31 March 2008, together with a Circular to Shareholders containing the Notice of the Company’s Annual General Meeting to be held at 12.00 noon on Tuesday 22 July 2008 at the offices of Ashurst LLP, Broadwalk House, 5 Appold Street, London EC2A 2HA, have been posted to shareholders today.
